title: After the Myriad decision: do hurdles remain for diagnostics competition?
authors.affiliation: Biotechnology Group, Wolf, Greenfield & Sacks, PC, Boston, MA, USA. pwaller@wolfgreenfield.com
authors.forename: Patrick R H
authors.initials: PR
authors.lastname: Waller
authors.forename: Daniel W
authors.initials: DW
authors.lastname: Young
mesh_terms: D004247:DNA / Q000302:isolation & purification*; D004465:Economic Competition; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D005820:Genetic Testing / Q000191:economics / Q000331:legislation & jurisprudence; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D035521:Supreme Court Decisions; D014481:United States
chemical_list: D004247:DNA